Institutional Ownership
Revelation Biosciences Inc
CUSIP 76135L804COM 2025REVBQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
10
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Armistice Capital, LLC | 323.2K | $387.9K |
| 2 | Sabby Management, LLC | 99.4K | $119.3K |
| 3 | Geode Capital Management, LLC | 43.2K | $51.8K |
| 4 | Xtx Topco Ltd | 11.4K | $13.7K |
| 5 | Ubs Group AG | 4.1K | $4.9K |
| 6 | Tower Research Capital LLC (Trc) | 4.1K | $4.9K |
| 7 | Royal Bank Of Canada | 747 | $1.0K |
| 8 | Sbi Securities Co., Ltd. | 344 | $413 |
| 9 | Bnp Paribas Asset Management Holding S.A. | 9 | $11 |
| 10 | Caitong International Asset Management Co., Ltd | 1 | $1 |